Who backs ILiAD Biotechnologies?
11 investors| Investor | Type |
|---|---|
| RA Capital Management | Asset manager |
| National Institutes of Health | Other |
| European Union | Other |
| BNP Paribas Asset Management | Asset manager |
| Knott Partners Management | Hedge fund |
| SDS Capital | Hedge fund |
| Endo Investors | — |
| Janus Henderson Investors | — |
| Network-1 Technologies | — |
| Seedlings Life Science Ventures | — |
| + 1 more investors · a free account shows the complete list | |
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns
Membership and data by Private Market View
ILiAD Biotechnologies investors
11 investors are on record for ILiAD Biotechnologies, including RA Capital Management, National Institutes of Health, European Union and BNP Paribas Asset Management. The Series B in Feb 2026 drew 2 investors.
Free account
More of ILiAD Biotechnologies with a free account
- ·The complete investor list: 11 names
- ·Watch ILiAD Biotechnologies: the Monday email on marks, rounds and moves
For fundraisers
Work this list, don’t just read it
These 11 firms already write checks for companies like ILiAD Biotechnologies in drug discovery. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.
Membership and data by Private Market View